Lv3
330 积分 2022-08-12 加入
Rational strategies for improving the efficiency of design and discovery of nanomedicines
1个月前
已完结
Template-dependent DNA ligation for the synthesis of modified oligonucleotides
1个月前
已完结
Evolving a terminal deoxynucleotidyl transferase for commercial enzymatic DNA synthesis
1个月前
已完结
Template-independent enzymatic synthesis of RNA oligonucleotides
2个月前
已完结
Chemistry of Peptide-Oligonucleotide Conjugates: A Review
2个月前
已完结
Expanding Conjugate Space of RNAi Therapeutics: Ligand at the 3′ End of the Antisense Strand Achieves Uncompromised In Vivo Potency and Efficacy and Reveals Interactions with the Argonaute-2 PAZ Domain
2个月前
已完结
First approval of a complement C3 inhibitor opens up autoimmune and inflammatory opportunities
2个月前
已完结
A Platform for Controlled Template-Independent Enzymatic Synthesis of RNA Oligonucleotides and Therapeutics
3个月前
已完结
Nanotechnology used for siRNA delivery for the treatment of neurodegenerative diseases: Focusing on Alzheimer’s disease and Parkinson’s disease
3个月前
已完结
Platform Strategies for Synthetic Oligonucleotide Drug Substances
4个月前
已完结
皖公网安备34019202002308
